Search academic texts

Information × Registration Number 0203U000735, 0100U000705 , R & D reports Title The investigation of lymphocyte antitumor affect to chemioresistant tumor cells popup.stage_title Head Berezhnaya N.M., Registration Date 05-03-2003 Organization R.E. Kavetsky Institute of Experimental Pathology, Oncology and Radiobiology popup.description2 Under the basis of the receipt dates experimental adoptive immunotherapy approaches have been proved. Different schemes comparative estimation efficacy of this therapy in mice with transplated Mh-rhabdomiosarcoma resistant to doxorubicin have been shown that local LAK injection and local LAK injection with systemic small dose doxorubicin injection were the most effective (tumor growth inhibition and survival enhancion). Product Description popup.authors popup.nrat_date 2020-04-02 Close